Skip to main content

Advertisement

SpringerLink
Log in

Who should pay for home monitoring of heart failure?

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Despite the recent advancement in medical therapy for heart failure, morbidity associated with heart failure continues to be excessive, with rising hospitalization rates and costs. Disease management models have been instituted successfully for several chronic disease states, and observational trials have shown different models to be beneficial. A multidisciplinary approach to management of heart failure improves outcomes. Multiple recent trials involving various models of integrated and comprehensive disease management have demonstrated promising results, such as reduction in mortality and hospitalizations. Future models for disease monitoring may include implantable devices that directly monitor hemodynamics combined with multidisciplinary care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987, 316:1429–1435.

    Article  Google Scholar 

  2. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991, 325:293–302.

    Article  Google Scholar 

  3. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992, 327:685–691.

    Article  Google Scholar 

  4. MERIT-HF Study Group: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERITHF). Lancet 1999, 353:2001–2007.

    Article  Google Scholar 

  5. Packer M, Bristow MR, Cohn JN, et al., the US Carvedilol Heart Failure Study Group: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996, 334:1349–1355.

    Article  PubMed  CAS  Google Scholar 

  6. Packer M, Coats AJS, Fowler MB, et al., the Carvedilol Prospective Randomized Cumulative Survival Study Group: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001, 344:1651–1658.

    Article  PubMed  CAS  Google Scholar 

  7. Pitt B, Zannad F, Remme WJ, et al., the Randomized Aldactone Evaluation Study Investigators: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709–717.

    Article  PubMed  CAS  Google Scholar 

  8. Pitt B, Remme W, Zannad F, et al., the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003, 348:1309–1321.

    Article  PubMed  CAS  Google Scholar 

  9. Cohn JN, Tognoni G, the Valsartan Heart Failure Trial Investigators: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001, 345:1667–1675.

    Article  PubMed  CAS  Google Scholar 

  10. Pfeffer MA, Swedberg K, Granger CB, et al.: Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. The Lancet 2003, 362:759–766.

    Article  CAS  Google Scholar 

  11. Cleland JG, Khand A, Clark A: The heart failure epidemic: exactly how big is it? Eur Heart J 2001, 22:623–626.

    Article  PubMed  CAS  Google Scholar 

  12. Krumholz HM, Parent EM, Tu N, Vaccarino V, et al.: Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997, 157:99–104.

    Article  PubMed  CAS  Google Scholar 

  13. Packer M, Califf RM, Konstam MA, et al., for the OVERTURE Study Group: Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE). Circulation 2002, 106:920–926.

    Article  PubMed  CAS  Google Scholar 

  14. Mann DL, McMurray JJV, Packer M, et al.: Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 2004, 109:1594–1602.

    Article  PubMed  CAS  Google Scholar 

  15. Kaluski E, Kobrin I, Zimlichman R, et al.: RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study. J Am Coll Cardiol 2003, 41:204–210.

    Article  PubMed  CAS  Google Scholar 

  16. Heart Disease and Stroke Statistics — 2005 Update. Dallas: American Heart Association; 2005.

  17. Massie BM, Shah NB: Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997, 133:703–712.

    Article  PubMed  CAS  Google Scholar 

  18. O’Connell JB: The economic burden of heart failure. Clin Cardiol 2000, 23:III610.

    Google Scholar 

  19. O’Connell JB, Bristow MR: Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994, 13:S107-S112.

    PubMed  CAS  Google Scholar 

  20. Wexler DJ, Chen J, Smith GL, et al.: Predictors of costs of caring for elderly patients discharged with heart failure. Am Heart J 2001, 142:350–357.

    Article  PubMed  CAS  Google Scholar 

  21. Rich MW, Beckham V, Wittenberg C, et al.: A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995, 333:1190–1195. This is a landmark study evaluating a nurse-led DM program for HF. This DM program resulted in significant reductions in hospitalizations and HF costs.

    Article  PubMed  CAS  Google Scholar 

  22. Fonarow GC, Yancy CW, Heywood JT, for the ADHERE Scientific Advisory Committee, Study Group, and Investigators: Adherence to heart failure quality-of-care indicators in us hospitals: analysis of the ADHERE Registry. Arch Intern Med 2005, 165:1469–1477.

    Article  PubMed  Google Scholar 

  23. Shibata MC, Nilsson C, Hervas-Malo M, et al.: Economic implications of treatment guidelines for congestive heart failure. Can J Cardiol 2005, 21:1301–1306.

    PubMed  Google Scholar 

  24. Coleman EA, Grothaus LC, Sandhu N, et al.: Chronic care clinics: a randomized controlled trial of a new model of primary care for frail older adults. J Am Geriatr Soc 1999, 47:775–783.

    PubMed  CAS  Google Scholar 

  25. Mangan M: Diabetes self-management education programs in the Veterans Health Administration. Diabetes Educ. 1997, 23:687–692, 695.

    Article  PubMed  CAS  Google Scholar 

  26. DeBusk RF, West JA, Miller NH, et al.: Chronic disease management: treating the patient with disease(s) vs treating disease(s) in the patient. Arch Intern Med 1999, 159:2739–2742.

    Article  PubMed  CAS  Google Scholar 

  27. Disease Management association of America: DMAA Definition of Disease Management. Accessible at http://www.dmaa.org/definition.html

  28. Perlman LV, Isenberg EL, Donovan I, et al.: Public health nurses and the prevention of recurrences of congestive heart failure. Geriatrics 1969, 24:82–89.

    PubMed  CAS  Google Scholar 

  29. Krumholz HM, Amatruda J, Smith GL, et al.: Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 2002, 39:83–89.

    Article  PubMed  Google Scholar 

  30. Shah NB, Der E, Ruggerio C, et al.: Prevention of hospitalizations for heart failure with an interactive home monitoring program. Am Heart J 1998, 135:373–378.

    Article  PubMed  CAS  Google Scholar 

  31. West JA, Miller NH, Parker KM, et al.: A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol 1997, 79:58–63.

    Article  PubMed  CAS  Google Scholar 

  32. Riegel B, Carlson B, Kopp Z, et al.: Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med 2002, 162:705–712.

    Article  PubMed  Google Scholar 

  33. DeBusk RF, Miller NH, Parker KM, et al.: Care management for low-risk patients with heart failure: a randomized, controlled trial. Ann Intern Med 2004, 141:606–613.

    PubMed  Google Scholar 

  34. Dunagan W, Littenberg B, Ewald GA, et al.: Randomized trial of a nurse-administered, telephone-based disease management program for patients with heart failure. J Card Fail 2005, 11:358–365.

    Article  PubMed  Google Scholar 

  35. Laramee AS, Levinsky SK, Sargent J, et al.: Case management in a heterogeneous congestive heart failure population: a randomized controlled trial. Arch Intern Med 2003, 163:809–817.

    Article  PubMed  Google Scholar 

  36. Galbreath AD, Krasuski RA, Smith B, et al.: Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 2004, 110:3518–3526.

    Article  PubMed  Google Scholar 

  37. Kimmelstiel C, Levine D, Perry K, et al.: Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF Trial. Circulation 2004, 110:1450–1455.

    Article  PubMed  Google Scholar 

  38. GESICA Investigators: Randomised trial of telephone inter vention in chronic heart failure: DIAL trial. BMJ 2005, 331:425. Conducted in Argentina, this is the largest trial of telephone home monitoring for HF.

    Article  Google Scholar 

  39. Heidenreich PA, Ruggerio CM, Massie BM: Effect of a home monitoring system on hospitalization and resource use for patients with heart failure. Am Heart J 1999, 138(4 Pt 1):633–640.

    Article  PubMed  CAS  Google Scholar 

  40. Grancelli H, Varini S, Ferrante D, et al.: Randomized Trial of Telephone Intervention in Chronic Heart Failure (DIAL): study design and preliminary observations. J Card Fail 2003, 9:172–179.

    Article  PubMed  Google Scholar 

  41. Andrews D, Gouda MS, Higgins S, et al.: A comparative study of a new wireless continuous cardiorespiratory monitor for the diagnosis and management of patients with congestive heart failure at home. J Telemed Telecare 2002, 8:361.

    Article  Google Scholar 

  42. de Lusignan S, Wells S, Johnson P, et al.: Compliance and effectiveness of 1 year’s home telemonitoring. The report of a pilot study of patients with chronic heart failure. Eur J Heart Failure 2001, 3:723–730.

    Article  Google Scholar 

  43. Jerant A, Azari R, Nesbitt T, et al.: Reducing the cost of frequent hospital admissions for congestive heart failure: a randomized trial of a home telecare intervention. Medical Care 2001, 39:1234–1245.

    Article  PubMed  CAS  Google Scholar 

  44. Artinian NT, Harden JK, Kronenberg MW, et al.: Pilot study of a Web-based compliance monitoring device for patients with congestive heart failure. Heart Lung 2003, 32:226–233.

    Article  PubMed  Google Scholar 

  45. Goldberg LR, Piette JD, Walsh MN, et al. The WHARF Investigators: Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J 2003, 146(4):705–712. The first trial to examine the effect of a technology-based daily weight and symptom management in patients with advanced HF.

    Article  PubMed  Google Scholar 

  46. Cleland JG, Louis AA, Rigby AS, et al.: Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 2005, 45(10):1654–1664. This is a large, recent randomized trial of home telemonitoring in high-risk HF patients.

    Article  PubMed  Google Scholar 

  47. Scalvini S, Capomolla S, Zanelli E, et al.: Effect of homebased telecardiology: costs and outcomes. J Telemed Telecare 2005, 11(Suppl 1):16–18.

    Article  PubMed  Google Scholar 

  48. Steimle AE, Stevenson LW, Chelimsky-Fallick C, et al.: Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation 1997, 96:1165–1172.

    PubMed  CAS  Google Scholar 

  49. The ESCAPE Investigators and ESCAPE Study Coordinators: Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness: the ESCAPE Trial. JAMA 2005, 294:1625–1633.

    Article  Google Scholar 

  50. Ohlsson A, Bennett T, Ottenhoff F, et al.: Long-term recording of cardiac output via an implantable haemodynamic monitoring device. Eur Heart J 1996, 17:1902–1910.

    PubMed  CAS  Google Scholar 

  51. Ohlsson A, Nordlander R, Bennett T, et al.: Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur Heart J 1998, 19:174–184.

    Article  PubMed  CAS  Google Scholar 

  52. Ohlsson A, Kubo SH, Steinhaus D, et al.: Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study. Eur Heart J 2001, 22:942–954.

    Article  PubMed  CAS  Google Scholar 

  53. Steinhaus D, Reynolds DW, Gadler F, et al.: Implant experience with an implantable hemodynamic monitor for the management of symptomatic heart failure. Pacing Clin Electrophysiol 2005, 28:747–753.

    Article  PubMed  Google Scholar 

  54. Adamson PB, Magalski A, Braunschweig F, et al.: Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 2003, 19:565–571.

    Article  Google Scholar 

  55. Massie BM, Shah NB: Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997, 133:703–712.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, University of Minnesota, 420 Delaware Street SE, MMC 508, 55416, Minneapolis, MN, USA

    Monica Colvin Adams MD

Authors
  1. Monica Colvin Adams MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Syed Sohail Ali MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monica Colvin Adams MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adams, M.C., Ali, S.S. Who should pay for home monitoring of heart failure?. Curr Cardiol Rep 8, 191–197 (2006). https://doi.org/10.1007/s11886-006-0033-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-006-0033-y

Keywords

Search

Navigation